Balance Sheet Data

Edwards Lifesciences Corporation (EW)

$69.18

+0.92 (+1.35%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 956.501,516.901,402.601,466.801,215.301,694.651,863.402,048.962,252.992,477.34
Total Cash (%)
Account Receivables 537.30599.10602.80664.90699.10800.76880.49968.171,064.581,170.59
Account Receivables (%)
Inventories 607640.90802.30726.70875.50940.911,034.601,137.621,250.911,375.47
Inventories (%)
Accounts Payable 134180.40196.50204.50201.90235.41258.85284.62312.96344.13
Accounts Payable (%)
Capital Expenditure -241.70-278.40-407.30-329.80-264.80-395.39-434.76-478.06-525.66-578.01
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.